Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the report by the Joint Committee on Vaccinations and Immunisation (JCVI) JCVI: updated interim advice on priority groups for COVID-19 vaccination, published on 25 September, how the JCVI will define which underlying health conditions present the greatest risk of morbidity and mortality from COVID-19; and what evidence it will take into account.

The Joint Committee on Vaccination and Immunisation (JCVI), and the JCVI sub-committee on COVID-19 are currently reviewing evidence on clinical risk factors associated with serious disease and mortality from COVID-19. Following a review of the evidence the Committee will develop advice on risk groups for any future COVID-19 vaccination programme. The evidence the JCVI will consider include data from Public Health England, OpenSAFELY and QCOVID.

The minutes of the JCVI committee meetings and statements on COVID-19 vaccination are published online.